Eric Meissner to Transforming Growth Factor beta3
This is a "connection" page, showing publications Eric Meissner has written about Transforming Growth Factor beta3.
Connection Strength
0.134
-
Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial. Liver Int. 2016 12; 36(12):1783-1792.
Score: 0.134
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.